Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591015793> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2591015793 endingPage "221" @default.
- W2591015793 startingPage "221" @default.
- W2591015793 abstract "221 Background: The benefits of chemoradiation therapy in patients with locally advanced pancreatic cancer (LAPC) are limited due to the inherent radioresistance of pancreatic cancer (PC) and high systemic toxicity of current radiosensitizers (e.g., gemcitabine). Hence, the search for newer radiosensitizers with unique anticancer properties continues. Single amino acid arginine starvation is a new promising therapeutic approach for solid tumors (e.g., PC), that are auxotrophic for non-essential amino acids. Arginine degrading enzyme, arginine deiminase (ADI), deprives cells of arginine and thereby exerts its anti-proliferative effects, especially in cancer cells deficient in enzyme argininosuccinate synthase (ASS1). Here we evaluate the effects of ADI-polyethylene glycol formulation (ADI-PEG20) as a radiosensitizer in PC. Methods: The toxicity of ADI-PEG20 in vitro was evaluated using XTT. Effect of ADI-PEG20 as radiosensitizer was determined by clonogenic cell survival. For in vivo, mice with PC tumor xenografts (Panc1), randomized into four groups, were treated with vehicle (PBS), ADI-PEG20 (5 IU/mouse; twice weekly), radiation (IR; 2 Gy × 5 times), and ADI-PEG20 with IR. Tumors were measured following treatment and the tumor re-growth delay time for each group was calculated. Immunohistochemical analysis of Ki-67 and VEGF was done on tumor tissues (paraffin sections) by routine immunofluorescence. Results: ADI-PEG20 selectively sensitized ASS1 deficient PC cells to IR at low, non-toxic concentrations (0.04 and 0.08 μg/mL for 72 h; DER at 10% SF for Panc1 was 1.39 and 1.52; for Miapaca-2, 1.09 and 1.25 respectively), but not ASS1 positive cells (L3.6pl). In vivo, ADI-PEG20 profoundly sensitized PC cells to IR. IR treatment alone delayed the tumor doubling time (7.6 ± 1.7 days compared to the non-treated controls); however, combining ADI-PEG20 with IR delayed the tumor growth by an additional 10 ± 1.3 days (p<0.05). Immunohistochemical analysis of tumor tissues suggested that ADI-PEG20 with IR down-regulates the expression of Ki-67 and VEGF. Conclusions: ADI-PEG20 potently radiosensitizes PC cells in vitro and in vivo. The detailed molecular mechanism of this radiosensitization warrants further investigations." @default.
- W2591015793 created "2017-03-03" @default.
- W2591015793 creator A5007808102 @default.
- W2591015793 creator A5013602233 @default.
- W2591015793 creator A5026913056 @default.
- W2591015793 creator A5042803045 @default.
- W2591015793 creator A5065509429 @default.
- W2591015793 creator A5084806711 @default.
- W2591015793 date "2014-01-20" @default.
- W2591015793 modified "2023-09-26" @default.
- W2591015793 title "Arginine deiminase: A novel radiosensitizer in pancreatic cancer in vitro and in vivo." @default.
- W2591015793 doi "https://doi.org/10.1200/jco.2014.32.3_suppl.221" @default.
- W2591015793 hasPublicationYear "2014" @default.
- W2591015793 type Work @default.
- W2591015793 sameAs 2591015793 @default.
- W2591015793 citedByCount "1" @default.
- W2591015793 countsByYear W25910157932016 @default.
- W2591015793 crossrefType "journal-article" @default.
- W2591015793 hasAuthorship W2591015793A5007808102 @default.
- W2591015793 hasAuthorship W2591015793A5013602233 @default.
- W2591015793 hasAuthorship W2591015793A5026913056 @default.
- W2591015793 hasAuthorship W2591015793A5042803045 @default.
- W2591015793 hasAuthorship W2591015793A5065509429 @default.
- W2591015793 hasAuthorship W2591015793A5084806711 @default.
- W2591015793 hasConcept C117262875 @default.
- W2591015793 hasConcept C121608353 @default.
- W2591015793 hasConcept C126322002 @default.
- W2591015793 hasConcept C150903083 @default.
- W2591015793 hasConcept C185592680 @default.
- W2591015793 hasConcept C188610204 @default.
- W2591015793 hasConcept C202751555 @default.
- W2591015793 hasConcept C207001950 @default.
- W2591015793 hasConcept C2776428644 @default.
- W2591015793 hasConcept C2777186326 @default.
- W2591015793 hasConcept C2777468819 @default.
- W2591015793 hasConcept C2779129087 @default.
- W2591015793 hasConcept C2780210213 @default.
- W2591015793 hasConcept C2780258809 @default.
- W2591015793 hasConcept C502942594 @default.
- W2591015793 hasConcept C509974204 @default.
- W2591015793 hasConcept C515207424 @default.
- W2591015793 hasConcept C55493867 @default.
- W2591015793 hasConcept C71924100 @default.
- W2591015793 hasConcept C86803240 @default.
- W2591015793 hasConcept C98274493 @default.
- W2591015793 hasConceptScore W2591015793C117262875 @default.
- W2591015793 hasConceptScore W2591015793C121608353 @default.
- W2591015793 hasConceptScore W2591015793C126322002 @default.
- W2591015793 hasConceptScore W2591015793C150903083 @default.
- W2591015793 hasConceptScore W2591015793C185592680 @default.
- W2591015793 hasConceptScore W2591015793C188610204 @default.
- W2591015793 hasConceptScore W2591015793C202751555 @default.
- W2591015793 hasConceptScore W2591015793C207001950 @default.
- W2591015793 hasConceptScore W2591015793C2776428644 @default.
- W2591015793 hasConceptScore W2591015793C2777186326 @default.
- W2591015793 hasConceptScore W2591015793C2777468819 @default.
- W2591015793 hasConceptScore W2591015793C2779129087 @default.
- W2591015793 hasConceptScore W2591015793C2780210213 @default.
- W2591015793 hasConceptScore W2591015793C2780258809 @default.
- W2591015793 hasConceptScore W2591015793C502942594 @default.
- W2591015793 hasConceptScore W2591015793C509974204 @default.
- W2591015793 hasConceptScore W2591015793C515207424 @default.
- W2591015793 hasConceptScore W2591015793C55493867 @default.
- W2591015793 hasConceptScore W2591015793C71924100 @default.
- W2591015793 hasConceptScore W2591015793C86803240 @default.
- W2591015793 hasConceptScore W2591015793C98274493 @default.
- W2591015793 hasIssue "3_suppl" @default.
- W2591015793 hasLocation W25910157931 @default.
- W2591015793 hasOpenAccess W2591015793 @default.
- W2591015793 hasPrimaryLocation W25910157931 @default.
- W2591015793 hasRelatedWork W1843927557 @default.
- W2591015793 hasRelatedWork W2021227763 @default.
- W2591015793 hasRelatedWork W2039035649 @default.
- W2591015793 hasRelatedWork W2057062457 @default.
- W2591015793 hasRelatedWork W2119097025 @default.
- W2591015793 hasRelatedWork W2166051826 @default.
- W2591015793 hasRelatedWork W2514829687 @default.
- W2591015793 hasRelatedWork W2591015793 @default.
- W2591015793 hasRelatedWork W2968530037 @default.
- W2591015793 hasRelatedWork W3180518876 @default.
- W2591015793 hasVolume "32" @default.
- W2591015793 isParatext "false" @default.
- W2591015793 isRetracted "false" @default.
- W2591015793 magId "2591015793" @default.
- W2591015793 workType "article" @default.